HealthLynked Delays Q3 2025 Filing

HealthLynked ( (HLYK) ) has released a notification of late filing.Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow. HealthLynked Corp., a Nevada-based company, has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The primary reason for this delay is the need for additional time to finalize the financial statements, which could not be completed without unreasonable effort or expense. The company anticipates filing the report within the five-day grace period allowed by the SEC. HealthLynked does not expect any significant changes in its financial results compared to the same period last year. The notification was signed by Jeremy Daniel, the Chief Financial Officer, who assured ongoing compliance efforts. The most recent analyst rating on (HLYK) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on HealthLynked stock, see the HLYK Stock Forecast page. Spark’s Take on HLYK Stock According to Spark, TipRanks’ AI Analyst, HLYK is a Underperform. The overall stock score for HealthLynked is low due to significant financial distress, characterized by declining revenues, high net losses, and negative equity. Technical analysis indicates a bearish trend, and the valuation is unattractive with a negative P/E ratio. These factors collectively contribute to a weak investment outlook. To see Spark’s full report on HLYK stock, click here. More about HealthLynked Average Trading Volume: 3,222 Technical Sentiment Signal: Sell Current Market Cap: $4.41M Find detailed analytics on HLYK stock on TipRanks’ Stock Analysis page.